CAM
TMO icon

Covenant Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Covenant Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Hold
0
– -$815K – 167
2022
Q2 		– Hold
0
– – – 94

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Covenant Asset Management's TMO Position: Q2 2026 in Review

Covenant Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 2.9% in Q2 2026, selling an estimated $36K and leaving 2,522 shares worth $1.26M. The position accounts for 0.21% of the portfolio, ranked #84.

Covenant Asset Management first reported a position in TMO in Q1 2019 and has held it in 30 quarters since. The position peaked at $1.87M in Q4 2021. 1,053 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Covenant Asset Management held 2,522 shares of Thermo Fisher Scientific worth $1.26M as of Q2 2026.
  • Covenant Asset Management sold 75 Thermo Fisher Scientific shares in Q2 2026, an estimated $36K.
  • Thermo Fisher Scientific made up 0.21% of Covenant Asset Management's portfolio in Q2 2026, its #84 holding.
  • Covenant Asset Management first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 30 quarters since.
  • Covenant Asset Management's Thermo Fisher Scientific position peaked at $1.87M in Q4 2021.
  • 1,053 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Covenant Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.